Table 1 summarizes the genetic heterogeneity of EGFR mutations identified in NSCLC patients, highlighting their exon locations, nucleotide changes, and associated COSMIC (Catalogue of Somatic Mutations in Cancer) IDs. This evidence concerns the gene EGFR and cancer.